Financials
Income statement
Fiscal date | Jan 2025 | Oct 2024 | Jul 2024 | Apr 2024 |
---|---|---|---|---|
Total reported revenue | 9.2B | 8.3B | 8.2B | 7.9B |
Cost of revenue | — | — | — | — |
Gross profit | — | — | — | — |
Operating expense | ||||
Research & development | — | — | — | — |
Selling general and admin | 3.4B | 2.9B | 2.9B | 2.8B |
Other operating expenses | — | — | — | — |
Operating income | — | — | — | — |
Non operating interest income | ||||
Income | — | — | — | — |
Expense | — | — | — | — |
Other income expense | — | — | — | — |
Pretax income | 2.8B | 3.0B | 2.4B | 2.4B |
Tax provision | 690M | 703M | 582M | 559M |
Net income | 2.1B | 2.3B | 1.9B | 1.9B |
Basic EPS | 2.8 | — | 2.5 | 2.4 |
Diluted EPS | 2.8 | — | 2.5 | 2.4 |
Basic average shares | 729.6M | — | 729.4M | 728.3M |
Diluted average shares | 730.7M | — | 730.2M | 729.3M |
EBITDA | — | — | — | — |
Net income from continuing op. | 2.1B | 2.3B | 1.9B | 1.9B |
Minority interests | -4M | -3M | 0 | -4M |
Preferred stock dividends | — | — | — | — |